Westphal Christoph H Insider Trades

Insider Trading History

Track insider trading activity for Westphal Christoph H. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tscan Therapeutics
Tscan Therapeutics TCRX
10% owner
Holding Value $1.24M 1,278,838 shares
Last Trade
Jul 20, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.41M 133,333 shares
$10.61
$0.97
Tscan Therapeutics
Tscan Therapeutics TCRX
10% owner
Holding Value $1.11M 1,145,505 shares
Last Trade
Jul 20, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$12.2M 1,145,505 shares
$10.61
$0.97
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
10% owner, President And CEO
Holding Value $2.54M 3,020,844 shares
Last Trade
May 12, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.6B 16,097 shares
$723,000.00
$0.84
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
10% owner, President And CEO
Holding Value $2.52M 3,004,747 shares
Last Trade
May 11, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.8B 14,120 shares
$767,250.00
$0.84
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
10% owner, President And CEO
Holding Value $2.51M 2,990,627 shares
Last Trade
May 10, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.52B 12,577 shares
$756,750.00
$0.84
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
10% owner, President And CEO
Holding Value $2.5M 2,978,050 shares
Last Trade
May 09, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12.9B 17,532 shares
$735,000.00
$0.84
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
10% owner, President And CEO
Holding Value $2.49M 2,960,518 shares
Last Trade
Mar 24, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$19B 24,207 shares
$786,000.00
$0.84
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
10% owner, President And CEO
Holding Value $2.47M 2,936,311 shares
Last Trade
Mar 23, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$21.7B 25,356 shares
$855,000.00
$0.84
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
10% owner, President And CEO
Holding Value $2.45M 2,910,955 shares
Last Trade
Mar 22, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$21.3B 23,951 shares
$891,000.00
$0.84
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
10% owner, President And CEO
Holding Value $2.45M 2,910,955 shares
Last Trade
Mar 21, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$42.5B 48,058 shares
$883,500.00
$0.84
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
10% owner, President And CEO
Holding Value $2.4M 2,862,897 shares
Last Trade
Mar 18, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$15.2B 18,437 shares
$825,750.00
$0.84
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
10% owner, President And CEO
Holding Value $2.39M 2,844,460 shares
Last Trade
Mar 17, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$15.6B 19,137 shares
$814,500.00
$0.84
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
10% owner, President And CEO
Holding Value $2.37M 2,825,323 shares
Last Trade
Mar 16, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$15.6B 19,142 shares
$817,500.00
$0.84
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
10% owner, President And CEO
Holding Value $2.36M 2,806,181 shares
Last Trade
Mar 15, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$13.7B 19,237 shares
$714,000.00
$0.84
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
10% owner, President And CEO
Holding Value $2.34M 2,786,944 shares
Last Trade
Mar 11, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$51.3B 89,680 shares
$571,500.00
$0.84
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
10% owner, President And CEO
Holding Value $138k 164,000 shares
Last Trade
Jan 21, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$118B 164,000 shares
$719,250.00
$0.84
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
10% owner, President And CEO
Holding Value $3.3M 3,925,248 shares
Last Trade
Dec 14, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$839M 927 shares
$905,250.00
$0.84
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
10% owner, President And CEO
Holding Value $3.3M 3,924,321 shares
Last Trade
Dec 07, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$821M 907 shares
$905,250.00
$0.84
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
10% owner, President And CEO
Holding Value $3.3M 3,923,414 shares
Last Trade
Nov 30, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$805M 887 shares
$907,500.00
$0.84
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
10% owner, President And CEO
Holding Value $3.29M 3,922,527 shares
Last Trade
Nov 23, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$843M 971 shares
$868,500.00
$0.84

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up